Switch to:
GuruFocus has detected 2 Warning Signs with Repros Therapeutics Inc \$RPRX.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Repros Therapeutics Inc (NAS:RPRX)
Revenue per Share
\$0.00 (TTM As of Dec. 2016)

Repros Therapeutics Inc's revenue per share for the three months ended in Dec. 2016 was \$0.00. Repros Therapeutics Inc's revenue per share for the trailing twelve months (TTM) ended in Dec. 2016 was \$0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

During the past 13 years, Repros Therapeutics Inc's highest 3-Year average Revenue Per Share Growth Rate was 302.10% per year. The lowest was 0.00% per year. And the median was -35.60% per year.

Definition

Revenue per Share is the amount of Revenue per outstanding share of the companys stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Repros Therapeutics Inc's Revenue Per Share for the fiscal year that ended in Dec. 2016 is calculated as

 Revenue Per Share (A: Dec. 2016 ) = Revenue (A: Dec. 2016 ) / Total Shares Outstanding (A: Dec. 2016 ) = 0.047 / 24.660 = 0.00

Repros Therapeutics Inc's Revenue Per Share for the quarter that ended in Dec. 2016 is calculated as

 Revenue Per Share (Q: Dec. 2016 ) = Revenue (Q: Dec. 2016 ) / Total Shares Outstanding (Q: Dec. 2016 ) = 0.006 / 24.660 = 0.00

Repros Therapeutics Inc Revenue Per Share for the trailing twelve months (TTM) ended in Dec. 2016 was 0.001 (Mar. 2016 ) + 0.001 (Jun. 2016 ) + 0 (Sep. 2016 ) + 0 (Dec. 2016 ) = \$0.00

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

 Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
 Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
 Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Related Terms

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Repros Therapeutics Inc Annual Data

 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 per share rev 0.48 0.13 0.13 0.05 0.00 0.00 0.00 0.00 0.00 0.00

Repros Therapeutics Inc Quarterly Data

 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 per share rev 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to \$400 per referral. ( Learn More)